NCT06447623 2024-06-07Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast CancerFudan UniversityPhase 3 Recruiting184 enrolled
NCT05861830 2024-03-12Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)Peking Union Medical College HospitalPhase 3 Recruiting80 enrolled